Mehran Pashirzad
Overview
Explore the profile of Mehran Pashirzad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pashirzad M, Kesharwani P, Sahebkar A
Pathol Res Pract
. 2024 Jul;
261:155475.
PMID: 39067174
The prognostic value of microRNA-140-5p (miR-140-5p) expression in cancer patients has been investigated, but with inconsistent results. This meta-analysis aims to determine the prognostic significance of miR-140-5p expression in patients...
2.
Pashirzad M, Sahebkar A
Curr Cancer Drug Targets
. 2024 Feb;
24(12):1286-1297.
PMID: 38409690
Background: Long non-coding RNA small nucleolar RNA host gene 5 (lncRNA SNHG5) has been identified as both a promising target for treatment and a predictor of prognosis in diverse types...
3.
Badakhshan S, Ghazizadeh H, Mohammadi-Bajgiran M, Esmaily H, Khorasani M, Bohn M, et al.
J Clin Lab Anal
. 2023 Dec;
37(23-24):e24995.
PMID: 38087776
Background: The reference intervals (RIs) for liver function tests (LFTs) were determined in Iranian children for the first time. Methods: A total of 344 healthy pediatrics aged 3 days to...
4.
Abdollahian N, Ghazizadeh H, Mohammadi-Bajgiran M, Pashirzad M, Khorasani M, Bohn M, et al.
J Cell Mol Med
. 2022 Dec;
27(1):158-162.
PMID: 36524863
Age and sex need to be considered in the establishment of reference intervals (RIs), especially in early life when there are dynamic physiological changes. Since data for important biomarkers in...
5.
Pashirzad M, Khorasanian R, Fard M, Arjmand M, Langari H, Khazaei M, et al.
Curr Cancer Drug Targets
. 2021 Nov;
21(11):932-943.
PMID: 34732116
The MAPK/ERK signaling pathway regulates cancer cell proliferation, apoptosis, inflammation, angiogenesis, metastasis and drug resistance. Mutations and up-regulation of components of the MAPK/ERK signaling pathway, as well as over-activation of...
6.
Pashirzad M, Johnston T, Sahebkar A
J Oncol
. 2021 Oct;
2021:3619510.
PMID: 34621313
Colorectal cancer (CRC) is the third most common cause of cancer-related death worldwide in terms of both its rates of incidence and mortality. Due to serious side effects associated with...
7.
Pashirzad M, Sathyapalan T, Sahebkar A
J Oncol
. 2021 Oct;
2021:3136508.
PMID: 34603445
Wnt5a is one of the potent signaling molecules that initiates responses involved in cancer through activation of both canonical and noncanonical signaling cascades. Wnt5a both directly and indirectly triggers cancer-associated...
8.
Pashirzad M, Fiuji H, Khazei M, Moradi-Binabaj M, Ryzhikov M, Shabani M, et al.
Mol Biol Rep
. 2019 Jun;
46(5):5609-5616.
PMID: 31236761
The Wnt signaling pathway plays a critical role in initiation, progression, invasion and metastasis of cancer. Wnt3a as a canonical Wnt ligand is strongly implicated in the etiology and pathology...
9.
Rezaei N, Avan A, Pashirzad M, Rahmani F, Moradi Marjaneh R, Behnam-Rassouli R, et al.
Drug Chem Toxicol
. 2019 Feb;
43(5):514-521.
PMID: 30714419
Ulcerative colitis is a chronic inflammatory bowel disease with high incidence and prevalence worldwide. To investigate the therapeutic potency of crocin, as a pharmacologically active component of saffron, in dextran...
10.
Pashirzad M, Shafiee M, Avan A, Ryzhikov M, Fiuji H, Bahreyni A, et al.
J Cell Physiol
. 2019 Jan;
234(9):14601-14611.
PMID: 30673132
Crocin is the major component of saffron, which is used in phytomedicine for the treatment of several diseases including diabetes, fatty liver, depression, menstruation disorders, and, of special interest in...